BlackRock Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
BIT
GCM
BA
BlackRock Group's ELV Position: Q4 2016 in Review
BlackRock Group increased its Elevance Health (ELV) stake by 1.9% in Q4 2016, buying an estimated $9.08M and bringing the position to 3,662,040 shares worth $526M. The position accounts for 0.25% of the portfolio, ranked #88.
BlackRock Group first reported a position in ELV in Q2 2013 and has held it in 15 quarters since. 784 funds tracked by Wall St. Rank hold ELV as of Q4 2016.
- BlackRock Group held 3,662,040 shares of Elevance Health worth $526M as of Q4 2016.
- BlackRock Group bought 67,828 Elevance Health shares in Q4 2016, an estimated $9.08M.
- Elevance Health made up 0.25% of BlackRock Group's portfolio in Q4 2016, its #88 holding.
- BlackRock Group first reported a position in Elevance Health in Q2 2013 and has held it in 15 quarters since.
- 784 funds tracked by Wall St. Rank held Elevance Health as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.